Alex A. Adjei, M.D., Ph.D., is Chair of Cleveland Clinic Taussig Cancer Institute. Previously, he served as a consultant in oncology, professor of oncology and professor of pharmacology at Mayo Clinic College of Medicine and Science in Rochester, Minn. He oversaw oncology drug development, lung cancer research, and treatment across various Mayo Clinic sites. He co-led the developmental therapeutics program at Mayo Clinic Cancer Center.
Dr. Adjei has focused his research on experimental therapeutics, regulatory science and clinical drug development. Other research interests include health disparities, global oncology, new drug treatments for lung cancer and the varying effects of drug toxicities on people. He has also contributed to the development of classical chemotherapy agents, targeted therapies, immunotherapy and cancer fighting viruses for the treatment of lung cancer and other solid tumors. Dr. Adjei has received the Adi F. Gazdar Merit Award from the International Association for the Study of Lung Cancer for Distinguished Achievement in Lung Cancer Research and Mentorship.
A native of Ghana, Dr. Adjei earned his medical degree from the University of Ghana Medical School and his Ph.D. from the University of Alberta in Edmonton, Canada. He was chief resident in the Department of Medicine at Howard University, and he completed a clinical fellowship as a clinical and research fellow in oncology at Johns Hopkins University.